Related Experiment Video
Updated: Mar 10, 2026

06:48
Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
Published on: January 7, 2019
9.6K
Attention-enhanced SAM with PBFO tuning: advancing glioma MRI segmentation
Salem Alhatamleh1, Hamad Yahia Abu Mhanna2, Mohammad Amin1
1Department of Computer Science, Faculty of Information Technology and Computer Sciences, Yarmouk University, Irbid, Jordan.
Frontiers in Medicine
|March 9, 2026
Summary
This study introduces PoSAM-ULTRA, an advanced framework for brain tumor MRI segmentation. It significantly improves accuracy and robustness in segmenting complex tumor tissues, outperforming existing models.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Computational Biology
Background:
- Brain tumor segmentation from MRI is complex due to tissue variability.
- Accurate segmentation is crucial for diagnosis and treatment planning.
- Existing methods face challenges with intricate tumor structures.
Purpose of the Study:
- To introduce PoSAM-ULTRA, an enhanced framework for brain tumor MRI segmentation.
- To improve the accuracy and robustness of automated segmentation.
- To address the challenges posed by complex tumor tissues.
Main Methods:
- PoSAM-ULTRA utilizes an improved Segment Anything Model backbone and a ResNet-34 encoder.
- Hyperparameter tuning is performed using the Polar-Bear Foraging Optimisation (PBFO) algorithm.
- Multi-scale feature extraction, attention mechanisms (CBAM, Attention Gates), and a multistage decoder are employed.
Main Results:
- PoSAM-ULTRA achieved a Dice score of 91.4%, IoU of 88.9%, Accuracy of 99.8%, Precision of 95.2%, and Recall of 93.3%.
- The framework demonstrated superior performance compared to UNet, UNet++, and nnUNet.
- The results highlight the model's effectiveness on the Lower Grade Gliomas (LGG) dataset.
Conclusions:
- PoSAM-ULTRA shows significant robustness and reliability in segmenting brain tumors.
- The framework is effective for challenging medical image segmentation tasks.
- This advancement offers a promising tool for clinical applications in neuro-oncology.

